TrialInvestigational new drugs2015

Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study.

Katrina S Pedersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.